![Radiation and Nuclear Medicine-We are aiming to develop novel diagnostic and therapeutic strategy for brain tumor by revealing prognostic marker-Ryuya Yamanaka](https://jndc-chemistryarticles.info/uploads/161229104558ryuya.png)
Japan
Assistant Professor Tomohiko Kanayama,
Postdoctoral Fellow & Secretary Azusa Hayano.
Ryuya Yamanaka
Address:
465 Kajii-cho, Kamigyoku
Kyoto 602-8566, Japan
Research Interests:
We are aiming to develop novel diagnostic and therapeutic strategy for brain tumor by revealing prognostic marker, biomarker and target molecule based on genome analysis. We are also interested in the research areas of clinical health science, clinical oncology and medical genetics.
Biography:
- Dr.Yamanaka is now a Professor at Kyoto Prefectural University of Medicine, Kyoto, Japan.
- He earned his MD at Niigata University, Japan, in 1982 and completed a neurosurgical residency training at its affiliated hospitals.
- He received his academic degree (Dr. Med. Sci.) from Niigata University. Following research fellowships at the National Institutes of Health in the United States from 1994 to 1998, he assumed the position of Assistant Professor and Lecturer at the Department of Neurosurgery in the Brain Research Institute at Niigata University.
- In 2006, he was promoted to Professor of the Research Center of Innovative Cancer Therapy at Kurume University School of Medicine.
- He joined the Faculty at Kyoto Prefectural University of Medicine in 2010.
- His main research interests include translational biochemical research in clinical oncology, including brain tumors.
- He has board certifications for Medical Oncology, Neurosurgery, Stroke and Cerebrovascular Diseases.